GeneNews Limited (GeneNews) is a Canada-based molecular diagnostics company. GeneNews is focused to become a leader in advanced diagnostics and personalized medicine, serving as a strong commercialization outlet for early detection of cancer and other chronic diseases. Company is also focused to identify and make commercially available a comprehensive menu of diagnostics that provide physicians and patients with personalized clinical intelligence and actionable information to improve health outcomes through the early diagnosis of disease. The Company offers services like: ColonSentry, which is a blood test that can assess a patient's current risk of having colorectal cancer. The test is not considered a replacement for colonoscopy, but rather a more convenient step in determining early warning signs of colon cancer, A 3-Dimensional Approach to Detecting & Treating Cancer; that provide physicians with clinical intelligence through early detection of disease and guiding treatment.